相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters
Zhiqi Song et al.
FRONTIERS IN MICROBIOLOGY (2021)
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
Rebecca L. Brocato et al.
NPJ VACCINES (2021)
Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters
Shinji Urata et al.
ACS CHEMICAL NEUROSCIENCE (2021)
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Nanda Kishore Routhu et al.
IMMUNITY (2021)
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
P. J. Klasse et al.
SCIENCE ADVANCES (2021)
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model
Sreelekshmy Mohandas et al.
ISCIENCE (2021)
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Robert H Shaw et al.
LANCET (2021)
MIXING COVID VACCINES TRIGGERS POTENT IMMUNE RESPONSE
Ewen Callaway
NATURE (2021)
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
Jean-Selim Driouich et al.
NATURE COMMUNICATIONS (2021)
THE CASE IS GROWING FOR MIX-AND-MATCH COVID VACCINES
Dyani Lewis
NATURE (2021)
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
Alina Tscherne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney
Magen Ellen Francis et al.
PLOS PATHOGENS (2021)
Protection against reinfection with D614-or G614-SARS-CoV-2 isolates in golden Syrian hamster
Marco Brustolin et al.
EMERGING MICROBES & INFECTIONS (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
Michael Chung et al.
RADIOLOGY (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Alba Grifoni et al.
CELL HOST & MICROBE (2020)
COVID-19 and Multiorgan Response
Sevim Zaim et al.
CURRENT PROBLEMS IN CARDIOLOGY (2020)
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
Zheng Ye et al.
EUROPEAN RADIOLOGY (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2
Jianzhong Shi et al.
SCIENCE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial
Till Koch et al.
LANCET INFECTIOUS DISEASES (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al.
LANCET INFECTIOUS DISEASES (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
Nikolaus Osterrieder et al.
VIRUSES-BASEL (2020)
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Tahmineh Mokhtari et al.
JOURNAL OF MOLECULAR HISTOLOGY (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
Lisa H. Tostanoski et al.
NATURE MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Mimi Guebre-Xabier et al.
VACCINE (2020)
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
Liqiang Feng et al.
NATURE COMMUNICATIONS (2020)
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
Jinsung Yang et al.
NATURE COMMUNICATIONS (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge
Yfat Yahalom-Ronen et al.
NATURE COMMUNICATIONS (2020)
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Tsun-Yung Kuo et al.
SCIENTIFIC REPORTS (2020)
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization
Brien K. Haun et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters
Andrew Chak-Yiu Lee et al.
CELL REPORTS MEDICINE (2020)
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
Kyle Rosenke et al.
EMERGING MICROBES & INFECTIONS (2020)
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
Boris R. Minev et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis
Ulrich M. Lauer et al.
CLINICAL CANCER RESEARCH (2018)
Reply to Bioinformatics Analysis of Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein
Siti Khadijah Kasani et al.
JOURNAL OF VIROLOGY (2017)
The gingival vein as a minimally traumatic site for multiple blood sampling in guinea pigs and hamsters
Mariana Valotta Rodrigues et al.
PLOS ONE (2017)
Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model
A. Phelps et al.
VACCINE (2017)
Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques
Rajesh Thippeshappa et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
Stephanie Downs-Canner et al.
MOLECULAR THERAPY (2016)
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Melanie Thompson et al.
PLOS ONE (2016)
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
Herbert J. Zeh et al.
MOLECULAR THERAPY (2015)
Langerin+ Dermal DC, but Not Langerhans Cells, Are Required for Effective CD8-Mediated Immune Responses after Skin Scarification with Vaccinia Virus
Julien Seneschal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Joost H. C. M. Kreijtz et al.
LANCET INFECTIOUS DISEASES (2014)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Integrin β1 Mediates Vaccinia Virus Entry through Activation of PI3K/Akt Signaling
Roza Izmailyan et al.
JOURNAL OF VIROLOGY (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination
Celine Verheust et al.
VACCINE (2012)
A vaccinia virus renaissance New vaccine and immunotherapeutic uses after smallpox eradication
Paulo H. Verardi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
Stephen R. Walsh et al.
EXPERT REVIEW OF VACCINES (2011)
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults
Jeffrey S. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Vaccinia virus vaccines: Past, present and future
Bertram L. Jacobs et al.
ANTIVIRAL RESEARCH (2009)
Smallpox vaccines: Past, present, and future
Janie Parrino et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
A rapid, simple, and humane method for submandibular bleeding of mice using a lancet
WT Golde et al.
LAB ANIMAL (2005)
Cutting edge:: Effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung
AD Roberts et al.
JOURNAL OF IMMUNOLOGY (2004)
Smallpox vaccination and bioterrorism with pox viruses
A Mayr
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
